Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             47 results found
no title author magazine year volume issue page(s) type
1 A case of early onset and late recognition of Fabry disease with generalized lymphadenopathy, anorchidism, hypergonadotropic hypogonadism, and growth retardation Sozin, S.E.
 2007
 29 S1 p. S27-S28
2 p.
 article
2 A case of Fabry disease with multiple sclerosis Bonometti, M.A.
 2007
 29 S1 p. S27-
1 p.
 article
3 Agalsidase beta treatment of patientswith Fabry disease for 54 months reduces globotriaosylceramide accumulation in multiple cell types of the kidney Waldek, S.
 2007
 29 S1 p. S29-S30
2 p.
 article
4 Assessing antibodies to α-galactosidase A in fabry disease Richards, Susan M.
 2007
 29 S1 p. S7-S8
2 p.
 article
5 “Atypical variant” and an indirect diagnosis of fabry disease in a patient with end-stage renal disease Ciabattini, F.
 2007
 29 S1 p. S26-S27
2 p.
 article
6 Cardiac involvement in fabry disease:About numbers and notions Strotmann, J.
 2007
 29 S1 p. S22-S23
2 p.
 article
7 Characterization of the somatosensorysensory profile of male patients with Fabry disease Maag, R.
 2007
 29 S1 p. S25-
1 p.
 article
8 Clinical benefits of early treatment with Fabrazyme in Fabry disease Waldek, S.
 2007
 29 S1 p. S29-
1 p.
 article
9 Clinical characteristics of Hungarianpatients with fabry disease Rákóczi, E.
 2007
 29 S1 p. S19-
1 p.
 article
10 Deterioration of renal function in young adult patients with fabry disease and proteinuria Bichet, D.G.
 2007
 29 S1 p. S33-
1 p.
 article
11 Diversity of neuropathy in a familywith Fabry disease Møller, A.T.
 2007
 29 S1 p. S24-S25
2 p.
 article
12 Effects of enzyme replacement therapyin Fabry neuropathy Politei, J.M.
 2007
 29 S1 p. S30-S31
2 p.
 article
13 End-stage renal disease in fabry disease Granata, A.
 2007
 29 S1 p. S20-
1 p.
 article
14 Evidence for selective low leukocyte enzyme activity levels associated with the G1170C>T 5'untranslated polymorphism of the α-galactosidase a gene Ferreira, S.
 2007
 29 S1 p. S28-S29
2 p.
 article
15 Fabrazyme® therapy in pediatric patients with Fabry disease: Improvements in quality-of-life measures Tylki-Szymanska, A.
 2007
 29 S1 p. S31-S32
2 p.
 article
16 Fabry disease and bilateral renal cell carcinoma Herrero, J.J.
 2007
 29 S1 p. S28-
1 p.
 article
17 Fabry disease: classic phenotype in alarge family affected by a novel mutation (A292T) in the α-galactosidase a gene Spanu, C.
 2007
 29 S1 p. S26-
1 p.
 article
18 Fabry disease model: A rational approach to the management of fabry disease Wanner, Christoph
 2007
 29 S1 p. S2-S5
4 p.
 article
19 Fabry disease: The need to stratify patient populations to better understand the outcome of enzyme replacement therapy Germain, Dominique P.
 2007
 29 S1 p. S17-S18
2 p.
 article
20 Fabry disease: Worsening of hearingloss with enzyme replacement therapy Moura, C.
 2007
 29 S1 p. S34-
1 p.
 article
21 Foreword Wanner, Christoph
 2007
 29 S1 p. S1-
1 p.
 article
22 Frequency of 5'untranslated region single nucleotide polymorphisms of the α-galactosidase a gene in the Portuguese population Ferreira, S.
 2007
 29 S1 p. S28-
1 p.
 article
23 Immunophenotyping of glomerular cellsin renal biopsies provides evidence of selective podocyte involvement in Fabry disease Franeta, A.-J.
 2007
 29 S1 p. S21-
1 p.
 article
24 Impact of treatment with agalsidasebeta on health-related quality of life in patients with Fabry disease Badia, X.
 2007
 29 S1 p. S31-
1 p.
 article
25 Intermitent long-term treatment in a patient with Fabry disease Del Pozo, C.
 2007
 29 S1 p. S32-
1 p.
 article
26 Long-term agalsidase beta therapy is associated with improvements in pain and quality of life among patients with Fabry disease Guffon, N.
 2007
 29 S1 p. S31-
1 p.
 article
27 Multisystemic cardiac involvement: Beyond left ventricular hypertrophy Zamorano, J.L.
 2007
 29 S1 p. S19-
1 p.
 article
28 Mutations in exon 7 of the α-galactosidase a gene Rosenberg, K.
 2007
 29 S1 p. S34-
1 p.
 article
29 Pediatrics: implementing the promise of early intervention for fabry disease Raas-Rothschild, Annick
 2007
 29 S1 p. S6-
1 p.
 article
30 Peripheral nervous system involvement in fabry disease: Role in morbidity and mortality Hilz, Max J.
 2007
 29 S1 p. S11-S12
2 p.
 article
31 Physical capacity and perception ofexertion in 72 patients with fabry disease Breunig, F.B.
 2007
 29 S1 p. S24-
1 p.
 article
32 Prevalence of fabry disease in a cohortof 479 unrelated patients with hypertrophic cardiomyopathy Monserrat, L.
 2007
 29 S1 p. S23-S24
2 p.
 article
33 Prevalence of fabry disease in malepatients with chronic renal disease not receiving renal replacement therapy: Preliminary report of a multicenter study Herrero, J.A.
 2007
 29 S1 p. S21-
1 p.
 article
34 Progression of fabry cardiomyopathy Strotmann, Jörg
 2007
 29 S1 p. S13-S14
2 p.
 article
35 Progression of left ventricularhypertrophy in fabry disease is faster in patients with phosphocreatine depletion: A phosphorus-31 magnetic resonance spectroscopy study Bultas, J.
 2007
 29 S1 p. S24-
1 p.
 article
36 Progressive development of microalbuminuria and proteinuria in males and females with fabry disease Ortiz, A.
 2007
 29 S1 p. S19-S20
2 p.
 article
37 Proteinuria signals the risk of diseaseprogression as strongly in female as in male patients with fabry disease Waldek, S.
 2007
 29 S1 p. S20-
1 p.
 article
38 Recent identification of a fabry kindred in rural Newfoundland, Canada Murphy, S.
 2007
 29 S1 p. S25-
1 p.
 article
39 Relationship between cardiac and kidneyinvolvement in fabry patients presenting with a classic phenotype Strotmann, J.
 2007
 29 S1 p. S22-
1 p.
 article
40 Relationship between chronic renal disease, blood pressure, and left ventricular hypertrophy in males and females with Fabry disease Ortiz, A.
 2007
 29 S1 p. S21-S22
2 p.
 article
41 Right ventricular involvement in Fabry disease Dostalova, G.
 2007
 29 S1 p. S23-
1 p.
 article
42 Staging of fabry disease using renal biopsies Oliveira, João Paulo
 2007
 29 S1 p. S15-S16
2 p.
 article
43 Stroke and brain structural alterations in fabry disease Fellgiebel, Andreas
 2007
 29 S1 p. S9-S10
2 p.
 article
44 The long-term effect of enzyme replacement therapy on regression of left ventricular hypertrophy in patients with Fabry cardiomyopathy. Impact of baseline findings Strotmann, J.
 2007
 29 S1 p. S30-
1 p.
 article
45 Unsuspected diagnosis of fabry disease in an 81-year-old male with microscopic polyangiitis Aaron, L.
 2007
 29 S1 p. S26-
1 p.
 article
46 Where are the deposits in cornea verticillata in fabry disease? Lanzl, I.
 2007
 29 S1 p. S25-
1 p.
 article
47 Withdrawal of enzyme replacement therapy in Fabry disease: Indirect evidence of treatment benefit? West, M.
 2007
 29 S1 p. S32-S33
2 p.
 article
                             47 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands